Kindeva Drug Delivery invests in sustainable manufacturing line for pMDIs
Kindeva Drug Delivery, a global leader in drug-device combination products, is expanding its production capacity with a new manufacturing line for pressurized metered-dose inhalers (pMDIs) using low-GWP (Global Warming Potential) propellants at its Loughborough, U.K. facility. This new line, expected to be operational in 2026, will handle HFA-152a and HFO-1234ze propellants, which offer GWPs 90% […]